# VISIONGATE INC: Form D filings

VISIONGATE INC, a biotechnology company in Phoenix, AZ, filed 19 Form D notices with the SEC between 2009 and 2019. The latest, on December 17, 2019, reports $36.6 million sold of a $43 million offering to 83 investors.

Find out what VISIONGATE INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20VISIONGATE%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=VISIONGATE%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fvisiongate-inc-1339362)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20VISIONGATE%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=VISIONGATE%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fvisiongate-inc-1339362)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Arizona](https://specstream.ai/data/form-d/state/arizona): 953 rows, by operating companies, filed since November 1, 2024, $47.65, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/arizona
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 10220 S. 51ST STREET, SUITE 2, Phoenix, AZ, 85044
- Phone: (602) 368-2118
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Washington
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1339362

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Dec 17, 2019 | Amendment | $43,000,001 | $36,563,440 | $6,436,561 | 83 | Jun 6, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1339362/000133936219000002/0001339362-19-000002-index.htm) |
| Aug 22, 2019 | New notice | $10,000,000 | $3,748,247 | $6,251,753 | 43 | Jun 6, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1339362/000133936219000001/0001339362-19-000001-index.htm) |
| Dec 19, 2018 | Amendment | $43,000,001 | $33,535,586 | $9,464,415 | 73 | Jun 6, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1339362/000133936218000001/0001339362-18-000001-index.htm) |
| Dec 20, 2017 | Amendment | $35,000,000 | $26,064,119 | $8,935,881 | 62 | Jun 6, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1339362/000133936217000002/0001339362-17-000002-index.htm) |
| Jun 26, 2017 | Amendment | $27,000,000 | $24,285,945 | $2,714,055 | 79 | Jun 6, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1339362/000133936217000001/0001339362-17-000001-index.htm) |
| Nov 21, 2016 | Amendment | $24,000,000 | $15,048,042 | $8,951,958 | 42 | Jun 6, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1339362/000133936216000006/0001339362-16-000006-index.htm) |
| May 10, 2016 | Amendment | $20,000,000 | $11,179,852 | $8,820,148 | 36 | Jun 6, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1339362/000133936216000005/0001339362-16-000005-index.htm) |
| Apr 14, 2016 | Amendment | $5,500,000 | $5,332,200 | $167,800 | 18 | Sep 30, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1339362/000133936216000004/0001339362-16-000004-index.htm) |
| Sep 22, 2015 | Amendment | $4,000,000 | $3,753,500 | $246,500 | 17 | Sep 30, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1339362/000133936215000002/0001339362-15-000002-index.htm) |
| May 26, 2015 | Amendment | $12,025,000 | $6,206,206 | $5,818,794 | 25 | Jun 6, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1339362/000133936215000001/0001339362-15-000001-index.htm) |
| Oct 10, 2014 | New notice | $3,000,000 | $800,000 | $2,200,000 | 2 | Sep 30, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1339362/000133936214000004/0001339362-14-000004-index.htm) |
| Jun 10, 2014 | Amendment | $12,025,000 | $4,847,253 | $7,177,747 | 14 | Jun 6, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1339362/000133936214000003/0001339362-14-000003-index.htm) |
| Jun 13, 2013 | New notice | $12,025,000 | $800,000 | $11,225,000 | 1 | Jun 6, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1339362/000133936213000001/0001339362-13-000001-index.htm) |
| Sep 21, 2012 | Amendment | $8,000,000 | $4,363,073 | $3,636,927 | 61 | Sep 6, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1339362/000133936212000002/0001339362-12-000002-index.htm) |
| Jul 24, 2012 | Amendment | $8,000,000 | $4,149,073 | $3,850,927 | 56 | Sep 6, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1339362/000133936212000001/0001339362-12-000001-index.htm) |
| Oct 11, 2011 | Amendment | $3,000,000 | $1,960,278 | $1,039,722 | 29 | Sep 6, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1339362/000133936211000002/0001339362-11-000002-index.htm) |
| Oct 12, 2010 | New notice | $3,000,000 | $125,000 | $2,875,000 | 2 | Sep 6, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1339362/000133936210000002/0001339362-10-000002-index.htm) |
| Sep 1, 2009 | Amendment | $3,500,000 | $1,780,000 | $1,720,000 | 17 | Jan 20, 2008 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1339362/000133936209000004/0001339362-09-000004-index.htm) |
| Apr 10, 2009 | New notice | $1,200,000 | $490,000 | $710,000 | 6 | Nov 6, 2008 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1339362/000133936209000003/0001339362-09-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Tanisha June-Nichole S. Villanueva | Executive Officer |  |
| Michael S. Doherty | Director |  |
| Alan C. Nelson | Executive Officer, Director |  |
| Maria C. Forero | Director |  |
| Walter C. Robb | Director |  |
| James S. Burns | Director |  |

## Other biotechnology companies in Arizona that filed recently

- [Gut-Brain-Axis Therapeutics Inc.](https://specstream.ai/data/form-d/company/gut-brain-axis-therapeutics-inc-1996678) $2 million · Oct 27, 2026
- [Avery Therapeutics, Inc.](https://specstream.ai/data/form-d/company/avery-therapeutics-inc-1708135) $8.5 million · Sep 21, 2026

[Every Form D from the week of Dec 16, 2019](https://specstream.ai/data/form-d/week/2019-12-16) · [All recent filings in Arizona](https://specstream.ai/data/form-d/state/arizona) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what VISIONGATE INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).